Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated With Symptomatic Intracerebral Hemorrhage
Author(s) -
Alfredo M. Lopez-Yunez,
Askiel Bruno,
Linda S. Williams,
Engin Y. Yilmaz,
Cristina Zurrú,
José Biller
Publication year - 2001
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.32.1.12
Subject(s) - medicine , intracerebral hemorrhage , stroke (engine) , thrombolysis , emergency medicine , emergency department , medical record , retrospective cohort study , anesthesia , subarachnoid hemorrhage , surgery , myocardial infarction , mechanical engineering , psychiatry , engineering
Recombinant tissue plasminogen activator (rTPA) is an established treatment for acute ischemic stroke. The rate and type of protocol violations in rTPA use and their effect on patient outcomes in this setting are not well understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom